Literature DB >> 27986133

Prevention and management of glucocorticoid-induced side effects: A comprehensive review: Gastrointestinal and endocrinologic side effects.

Avrom Caplan1, Nicole Fett2, Misha Rosenbach1, Victoria P Werth1, Robert G Micheletti3.   

Abstract

Part 2 of this 4-part continuing medical education series continues with a discussion of the prevention and management of gastrointestinal side effects associated with corticosteroid use, including peptic ulcer disease, gastrointestinal bleeding, and pancreatitis, followed by a review of corticosteroid-related endocrinologic side effects, such as diabetes, adrenal suppression, and Cushing syndrome.
Copyright © 2016 American Academy of Dermatology, Inc. All rights reserved.

Entities:  

Keywords:  Cushing syndrome; adrenal suppression; diabetes; gastrointestinal bleeding; glucocorticoids; peptic ulcer disease; side effects; steroids

Mesh：

Substances：

Year:  2017        PMID： 27986133     DOI： 10.1016/j.jaad.2016.02.1239

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


  21 in total

Review 1.  The Evolving Landscape of Cutaneous Sarcoidosis: Pathogenic Insight, Clinical Challenges, and New Frontiers in Therapy.

Authors:  Julie H Wu; Sotonye Imadojemu; Avrom S Caplan
Journal:  Am J Clin Dermatol       Date:  2022-05-18       Impact factor: 6.233

2.  Pediatric expert consensus on the application of glucocorticoids in Kawasaki disease.

Authors: 
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2022-03-15

Review 3.  Glucocorticoid treatment in juvenile idiopathic arthritis.

Authors:  Ezgi Deniz Batu
Journal:  Rheumatol Int       Date:  2018-10-01       Impact factor: 2.631

Review 4.  Pancreatic Disorders in Patients with Inflammatory Bowel Disease.

Authors:  Marilia L Montenegro; Juan E Corral; Frank J Lukens; Baoan Ji; Paul T Kröner; Francis A Farraye; Yan Bi
Journal:  Dig Dis Sci       Date:  2021-02-24       Impact factor: 3.199

Review 5.  Vaccines: Considerations for pediatric dermatology patients on immunosuppressive agents.

Authors:  Mumtaz A Munshi; Megan H Noe; Yvonne E Chiu; Jenna L Streicher
Journal:  Pediatr Dermatol       Date:  2021-06-01       Impact factor: 1.997

6.  Resveratrol Attenuates Microglial Activation via SIRT1-SOCS1 Pathway.

Authors:  Shuping Zhang; Lu Gao; Xiuying Liu; Tao Lu; Chuangbo Xie; Ji Jia
Journal:  Evid Based Complement Alternat Med       Date:  2017-07-11       Impact factor: 2.629

Review 7.  A Jack of All Trades: Impact of Glucocorticoids on Cellular Cross-Talk in Osteoimmunology.

Authors:  Mubashir Ahmad; Yasmine Hachemi; Kevin Paxian; Florian Mengele; Mascha Koenen; Jan Tuckermann
Journal:  Front Immunol       Date:  2019-10-17       Impact factor: 7.561

8.  Consensus on the treatment of alopecia areata - Brazilian Society of Dermatology.

Authors:  Paulo Müller Ramos; Alessandra Anzai; Bruna Duque-Estrada; Daniel Fernandes Melo; Flavia Sternberg; Leopoldo Duailibe Nogueira Santos; Lorena Dourado Alves; Fabiane Mulinari-Brenner
Journal:  An Bras Dermatol       Date:  2020-10-08       Impact factor: 1.896

9.  Cause-specific mortality in individuals with lymphoplasmacytic lymphoma/Waldenström macroglobulinaemia, 2000-2016.

Authors:  Nicole H Dalal; Graça M Dores; Rochelle E Curtis; Martha S Linet; Lindsay M Morton
Journal:  Br J Haematol       Date:  2020-02-23       Impact factor: 8.615

10.  Use of systemic corticosteroids for atopic dermatitis: International Eczema Council consensus statement.

Authors:  A M Drucker; K Eyerich; M S de Bruin-Weller; J P Thyssen; P I Spuls; A D Irvine; G Girolomoni; S Dhar; C Flohr; D F Murrell; A S Paller; E Guttman-Yassky
Journal:  Br J Dermatol       Date:  2018-01-28       Impact factor: 9.302
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.